These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15101567)

  • 21. Evaluation of the clinical efficacy of risperidone for untreated and treated cases of schizophrenia from various aspects.
    Himei A; Okamura T
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):556-62. PubMed ID: 16194258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
    Riedel M; Spellmann I; Strassnig M; Douhet A; Dehning S; Opgen-Rhein M; Valdevit R; Engel RR; Kleindienst N; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):360-70. PubMed ID: 17629731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insomnia related to biperiden withdrawal in two schizophrenic patients.
    Hirose S
    Int Clin Psychopharmacol; 2000 Nov; 15(6):357-9. PubMed ID: 11110012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No antidepressant effect of biperiden compared with placebo in depression: a double-blind 6-week clinical trial.
    Gillin JC; Lauriello J; Kelsoe JR; Rapaport M; Golshan S; Kenny WM; Sutton L
    Psychiatry Res; 1995 Sep; 58(2):99-105. PubMed ID: 8570773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
    Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G
    J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biperiden-Induced Delirium In A Five-Years Old Child.
    Kınay D; Soyata AZ
    Curr Drug Saf; 2019; 14(1):48-50. PubMed ID: 30370855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.
    Minzenberg MJ; Poole JH; Benton C; Vinogradov S
    Am J Psychiatry; 2004 Jan; 161(1):116-24. PubMed ID: 14702259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study.
    Zhong KX; Sweitzer DE; Hamer RM; Lieberman JA
    J Clin Psychiatry; 2006 Jul; 67(7):1093-103. PubMed ID: 16889453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Ratner Y; Gibel A; Yorkov V; Ritsner MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1401-9. PubMed ID: 17669574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.
    Lasser RA; Bossie CA; Zhu Y; Gharabawi G; Eerdekens M; Davidson M
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):898-905. PubMed ID: 15352149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Panic attacks in patients with chronic schizophrenia: a complication of long-term neuroleptic treatment.
    Higuchi H; Kamata M; Yoshimoto M; Shimisu T; Hishikawa Y
    Psychiatry Clin Neurosci; 1999 Feb; 53(1):91-4. PubMed ID: 10201291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biperiden for excessive sweating from methadone.
    Caflisch C; Figner B; Eich D
    Am J Psychiatry; 2003 Feb; 160(2):386-7. PubMed ID: 12562595
    [No Abstract]   [Full Text] [Related]  

  • 35. Biperiden withdrawal in schizophrenic inpatients receiving long-term antipsychotic medication.
    Wada Y; Koshino Y; Yamaguchi N
    Clin Neuropharmacol; 1987 Aug; 10(4):370-5. PubMed ID: 2902920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic.
    Fleischhacker WW; Eerdekens M; Karcher K; Remington G; Llorca PM; Chrzanowski W; Martin S; Gefvert O
    J Clin Psychiatry; 2003 Oct; 64(10):1250-7. PubMed ID: 14658976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of anticholinergic drugs in patients with schizophrenia in Asia from 2001 to 2009.
    Xiang YT; Wang CY; Si TM; Lee EH; He YL; Ungvari GS; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong KH; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
    Pharmacopsychiatry; 2011 May; 44(3):114-8. PubMed ID: 21491361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term use of quetiapine in elderly patients with psychotic disorders.
    Tariot PN; Salzman C; Yeung PP; Pultz J; Rak IW
    Clin Ther; 2000 Sep; 22(9):1068-84. PubMed ID: 11048905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is flunarizine a long-acting oral atypical antipsychotic? A randomized clinical trial versus haloperidol for the treatment of schizophrenia.
    Bisol LW; Brunstein MG; Ottoni GL; Ramos FL; Borba DL; Daltio CS; de Oliveira RV; Paz GE; de Souza SE; Bressan RA; Lara DR
    J Clin Psychiatry; 2008 Oct; 69(10):1572-9. PubMed ID: 19192440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Less is more: Deprescribing anticholinergic medications in persons with severe mental illness.
    Lupu AM; MacCamy KL; Gannon JM; Brar JS; Chengappa KNR
    Ann Clin Psychiatry; 2021 May; 33(2):80-92. PubMed ID: 33878282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.